Another life-saving drug to be made available

This week the Health Secretary announced that thousands of patients hospitalised with Covid-19 will now be able to receive the life-saving treatment, tocilizumab, which has shown to lower the risk of death and time spent in hospital, helping reduce pressures on our NHS over the coming weeks and months.

  • This excellent news once again demonstrates that Britain is at the forefront of the global mission to find safe and effective treatments for the virus, having discovered the world-first treatment of dexamethasone last June. 
  • Trials have shown that tocilizumab reduces the relative risk of death by 14 per cent and lowers the time spent in hospital by 5 days when used for patients on oxygen, on top of the benefits from dexamethasone, and can also help patients outside of intensive care with oxygen deficiency who are showing signs of worsening – and we are now working quickly to ensure it is available across the NHS. 
  • This marks yet another important advance in our fight against this terrible disease, and by ensuring every NHS patient who needs this treatment can access it, we can potentially help save thousands of more lives and alleviate the pressures on our NHS.  


Popular posts from this blog

Nick Herbert on his visit to flood hit areas of Cumbria

Quotes of the day 19th August 2020

Quote of the day 24th July 2020